PMDA drug package insert
アジマイシン点眼液1%
PMDA Prescription drug · 千寿製薬株式会社 · package insert Nov 4, 2022
Key facts
| Brand names | アジマイシン点眼液1% |
|---|---|
| Nonproprietary names | アジスロマイシン水和物 |
| Companies | 製造販売元／千寿製薬株式会社, 販売／武田薬品工業株式会社 |
| Product type | Prescription drug |
| Therapeutic category | 15員環マクロライド系抗生物質点眼剤 |
| Therapeutic category codes | 871317 |
| YJ codes | 1317714Q1024 |
| Approval numbers | 30100AMX00011 |
| Package insert edition | 第3版 |
| Package insert date | Nov 4, 2022 |
| PMDA document key | 380086_1317714Q1024_1 |
| PMDA company code | 380086 |
At a glance
- 1–9 Package insert revisions
- 1–9 Related PMDA documents
- None Safety communications
- Yes PMDA review report published
- Yes Risk management plan (RMP)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMDA approved drugs and package inserts (Japan)
Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date: